Literature DB >> 12047609

Hypnotic effects of total aqueous extracts of Vervain hastata (Verbenaceae) in rats.

Moses A Akanmu1, Kazuki Honda, Shojiro Inoué.   

Abstract

The in vivo sedative property of the total aqueous extract of the aerial portion of Vervain hastata (Verbenaceae) (TAEV) was studied in male rats to establish its scientific basis in herbal medicine. The investigation was conducted using electroencephalogram (EEG) analysis, and the barbituric-hypnosis test. The results showed that TAEV potentiated the pentobarbital-induced hypnosis significantly by reducing sleep latency and increased sleeping time in a dose-dependent manner that was reversed by flumazenil. The EEG data demonstrated that extract administration augmented total sleep time, rapid eye movement (REM) sleep and non-REM sleep at the expense of wakefulness. The study's results clearly showed the scientific validity for the use of this plant as a sedative and possibly as a nerve tonic substance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12047609     DOI: 10.1046/j.1440-1819.2002.01009.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  3 in total

1.  Antidepressive potential of aqueous extract of common vervain ( V. officinalis L. Verbenaceae) and molecular docking studies of its main components as potential antidepressive agents: PS097.

Authors:  N Lasica; V Raicevic
Journal:  Porto Biomed J       Date:  2017-09-01

2.  Comparative antileishmanial efficacy of the biosynthesised ZnO NPs from genus Verbena.

Authors:  Muhammad Siddique Afridi; Syed Salman Hashmi; Gul Shad Ali; Muhammad Zia; Bilal Haider Abbasi
Journal:  IET Nanobiotechnol       Date:  2018-12       Impact factor: 1.847

3.  Anticonvulsant Effects of Aerial Parts of Verbena officinalis Extract in Mice: Involvement of Benzodiazepine and Opioid Receptors.

Authors:  Amir Rashidian; Fatemeh Kazemi; Saeed Mehrzadi; Ahmad Reza Dehpour; Shahram Ejtemai Mehr; Seyed Mahdi Rezayat
Journal:  J Evid Based Complementary Altern Med       Date:  2017-06-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.